New Edge Advisors, LLC Pfizer Inc Transaction History

New Edge Advisors, LLC

$15 Billion
Q3 2024

A detailed history of New Edge Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, New Edge Advisors, LLC holds 579,033 shares of PFE stock, worth $15.3 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

579,033

Previous 468,311 23.64%

Holding current value

$15.3 Million

Previous $13.1 Million 27.89%

% of portfolio

0.11%

Previous 0.1%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $3.07 Million - $3.48 Million	110,722 Added 23.64%	579,033 $16.8 Million
Q2 2024 Aug 15, 2024	BUY	$25.26 - $29.6 $3.03 Million - $3.55 Million	120,082 Added 34.48%	468,311 $13.1 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $328,129 - $376,798	-12,674 Reduced 3.51%	348,229 $9.66 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $1.92 Million - $2.49 Million	-73,372 Reduced 16.9%	360,903 $10.4 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $1.2 Million - $1.4 Million	37,396 Added 9.42%	434,275 $14.4 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $1.47 Million - $1.7 Million	-40,783 Reduced 9.32%	396,879 $14.6 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $983,725 - $1.28 Million	24,974 Added 6.05%	437,662 $17.9 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $1.16 Million - $1.52 Million	27,859 Added 7.24%	412,688 $21.2 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $1.75 Million - $2.13 Million	-39,914 Reduced 9.4%	384,829 $16.8 Million
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $3.03 Million - $3.59 Million	65,080 Added 18.09%	424,743 $22.3 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $56,730 - $70,295	-1,240 Reduced 0.34%	359,663 $18.6 Million
Q4 2021 Feb 17, 2022	BUY	$41.32 - $61.25 $7.6 Million - $11.3 Million	183,976 Added 103.98%	360,903 $21.3 Million
Q3 2021 Oct 29, 2021	BUY	$39.25 - $50.42 $107,152 - $137,646	2,730 Added 1.57%	176,927 $7.61 Million
Q2 2021 Jul 22, 2021	BUY	$35.91 - $40.68 $544,395 - $616,708	15,160 Added 9.53%	174,197 $6.82 Million
Q1 2021 Apr 26, 2021	BUY	$33.49 - $37.77 $59,578 - $67,192	1,779 Added 1.13%	159,037 $5.76 Million
Q4 2020 Jan 27, 2021	SELL	$33.47 - $42.56 $79,491 - $101,080	-2,375 Reduced 1.49%	157,258 $5.79 Million
Q3 2020 Nov 03, 2020	BUY	$31.75 - $37.25 $763,365 - $895,601	24,043 Added 17.73%	159,633 $5.86 Million
Q2 2020 Jul 29, 2020	BUY	$30.12 - $36.54 $232,797 - $282,417	7,729 Added 6.04%	135,590 $4.43 Million
Q1 2020 May 04, 2020	SELL	$27.03 - $38.62 $1.24 Million - $1.77 Million	-45,768 Reduced 26.36%	127,861 $4.17 Million
Q4 2019 Jan 31, 2020	BUY	$32.92 - $37.36 $907,077 - $1.03 Million	27,554 Added 18.86%	173,629 $6.8 Million
Q3 2019 Nov 06, 2019	BUY	$32.49 - $42.13 $931,000 - $1.21 Million	28,655 Added 24.4%	146,075 $5.27 Million
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $133,128 - $149,472	3,600 Added 3.16%	117,420 $5.09 Million
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $4.27 Million - $4.69 Million	113,820 New	113,820 $4.83 Million
Q1 2019 May 09, 2019	SELL	$37.5 - $41.2 $3.83 Million - $4.2 Million	-102,062 Closed	0 $0
Q4 2018 Jan 29, 2019	SELL	$38.47 - $43.86 $296,372 - $337,897	-7,704 Reduced 7.02%	102,062 $4.46 Million
Q3 2018 Oct 29, 2018	BUY	$34.47 - $41.81 $430,909 - $522,666	12,501 Added 12.85%	109,766 $4.84 Million
Q2 2018 Jul 19, 2018	BUY	$32.98 - $35.16 $677,771 - $722,573	20,551 Added 26.79%	97,265 $3.53 Million
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $94,645 - $109,801	2,966 Added 4.02%	76,714 $2.69 Million
Q4 2017 Feb 08, 2018	BUY	$33.26 - $35.29 $23,714 - $25,161	713 Added 0.98%	73,748 $2.69 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $234,484 - $258,310	7,564 Added 11.55%	73,035 $2.64 Million
Q2 2017 Aug 16, 2017	BUY	N/A	65,471	65,471 $0

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Account

New Edge Advisors, LLC Pfizer Inc Transaction History